Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179369 · ClinicalTrials.gov registry record · NA
Well-Mama Community Doula Navigator Study
A NA study of Pregnancy Related, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 576
- Enrollment target
- 2
- Study locations
NCT05179369: Recruiting NA study of Pregnancy Related, sponsored by Northwestern University.
NCT05179369 is a NA study of Pregnancy Related that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 576 participants, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05179369, a NA study of Pregnancy Related, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 576 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will develop and test an intervention, called the Well-Mama intervention, which includes the use of a checklist by Community Doula Navigators to support pregnant women. Participants will be randomized to either receive standard perinatal care or standard perinatal care plus the Well-Mama intervention.
Primary Outcome
The primary outcome will be a composite proportion of perinatal care components across three domains, including prenatal care, postpartum care, and social determinants of health content compared between participants in the intervention and control arms.
Conditions Studied
Interventions
- BEHAVIORAL Standard Care with Well-Mama Intervention
Study Locations (2)
Louisiana
- Woman's Hospital - Baton Rouge
New Jersey
- University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2023-05-07 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05179369 shows while recruiting
NCT05179369 is an interventional study that assigns participants to a tested intervention. The registered 576 participants enrollment target is mid-sized for trials with a published cap, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Standard Care with Well-Mama Intervention is the first listed.
NCT05179369 reports a single indexed study location in Louisiana, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05179369 about?
NCT05179369 is a clinical study titled "Well-Mama Community Doula Navigator Study". This study will develop and test an intervention, called the Well-Mama intervention, which includes the use of a checklist by Community Doula Navigators to support pregnant women. Participants will be randomized to either receive standard perinatal care or standard perinatal care plus the Well-Mama ...
What is the current status of trial NCT05179369?
This trial is currently recruiting. It is a NA study. The enrollment target is 576 participants. The study started on 2023-05-07. Estimated completion is 2025-12-31.
What conditions does trial NCT05179369 study?
This clinical trial studies the following conditions: Pregnancy Related.
What interventions are being tested in trial NCT05179369?
The interventions under investigation include: Standard Care with Well-Mama Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05179369?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05179369 being conducted?
This trial has 2 study locations across Louisiana, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05179369's enrollment target sits among peer trials
576 25th of 99 higher than 75 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04931810 · 576 participants · NA
Urban and Reservation Implementation of All Nations Breath of Life
- NCT06398509 · 576 participants · NA
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI